- Home
- / 4Basebio
4Basebio
Stock Price
€10.2
2021-04-01
Market Capitalization
€93.9 M
2021-04-01
4Basebio Summary
Company Summary
- Overview
- 4Basebio (formerly Expedeon) is a company that specializes in the manufacture and distribution of pharmaceutical grade DNA products. It offers DNA amplification kits, genome coverage WGA QC kits, DNA polymerases, and reverse transcriptase kits.
- Type
- Public
- Status
- Active
- Founded
- 1997
- HQ
- Cambridge, GB | view all locations
- Website
- https://www.4basebio.com/
- Cybersecurity rating
Table of Contents
Key People
David Roth, Chief Financial Officer
Heikki Lanckriet, Chief Executive Officer
Rainer Herschlein, Board Member
LocationsView all
1 location detected
Cambridge, England HQ
United Kingdom
25 Norman Way
4Basebio Financials
Summary Financials
- Gross profit (FY, 2025)
- €869.0K
- Net income (FY, 2025)
- €3.4M
- Cash (FY, 2025)
- €3.2M
- EBIT (FY, 2025)
- €359.0K